J&J's Drug Sales Help Health Giant Beat Earnings EstimatesBy
Company raises 2016 forecast, citing foreign exchange rates
Sales of medical devices, consumer products both decline
Johnson & Johnson reported earnings that beat analysts’ estimates on strong sales of pharmaceuticals, the company’s biggest division.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.